rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Steven Kornfeld

Director

Company insider

Files Form 4 as: Director, Forte Biosciences.

In numbers

Trades disclosed
28
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
15 Jun 2020
Last trade
27 Aug 2026
Last filed
27 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Forte BiosciencesDirector · Biotechnology · last 27 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
27 Aug 2026filed 27 Aug 2026Forte BiosciencesBiotechnologySEC FORM 4 Code U—3,960filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,200filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—800filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,200filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—800filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—2,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—31,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—18,353filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—2,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—31,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—18,353filing
27 Aug 2026filed 27 Aug 2026Forte BiosciencesBiotechnologySEC FORM 4 Code U—3,960filing
29 May 2026filed 2 Jun 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—18,353 at $0.00filing
29 May 2026filed 2 Jun 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—18,353 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

David W. GryskaDirector · Director at Forte Biosciences, filing Form 4 there in the last year
Barbara K. FinckDirector · Director at Forte Biosciences, filing Form 4 there in the last year
Richard G. VincentDirector · Director at Forte Biosciences, filing Form 4 there in the last year
Antony A. RileyChief Financial Officer · Chief Financial Officer at Forte Biosciences, filing Form 4 there in the last year
Stephen K. DobersteinDirector · Director at Forte Biosciences, filing Form 4 there in the last year